Skip to content
00 — MMXXVI Edition
Registration open

Accelerate the discovery of new medicines, without exposing sensitive data.

“How do you scale AI in sectors where data is sensitive, regulated and cannot be shared?”

This is today the main bottleneck for unlocking innovation in healthcare and pharma, with direct impact on human health. The ConvergeLab Summit connects science, regulation and market around a shared agenda.

Date
Oct 22 — 23
Thursday · Friday · 2026
Venue
Av. das Américas, 2480
Rio de Janeiro · BR
Edition
First · I
Founding Partners
Time remaining
000
Days
00
Hours
00
Min
00
Sec
IA Privada · Private AI ◆ Computação Federada · Federated Computing ◆ Soberania de Dados · Data Sovereignty ◆ Pharma 4.0 ◆ Saúde Digital · Digital Health ◆ LGPD ◆ Deep Tech ◆ Drug Discovery ◆ Open Innovation ◆ IA Privada · Private AI ◆ Computação Federada · Federated Computing ◆ Soberania de Dados · Data Sovereignty ◆ Pharma 4.0 ◆ Saúde Digital · Digital Health ◆ LGPD ◆ Deep Tech ◆ Drug Discovery ◆ Open Innovation ◆
01 — The Summit

Where open innovation meets data security .

02
Days of immersion
Oct 22 — 23
40+
Expected leaders
Keynotes & panels
06
Thematic tracks
From research to market
∞
Possible connections
Targeted matchmaking
1.1 — Audiences

Five communities, one shared agenda.

  • 01
    Startups & Deep Techs
    Seeking technological, regulatory and commercial validation.
  • 02
    Pharmaceutical Industry
    Looking for new routes of open and regulated innovation.
  • 03
    Hospitals, Labs & RTOs
    Capable of generating, qualifying and validating clinical data.
  • 04
    Regulators & Government
    Building safe environments for innovation in healthcare.
  • 05
    Investors, Funds & CVCs
    Reducing technological, regulatory and market risk.
02 — Tracks

Six tracks where science, regulation and market meet.

Each track is a research, regulatory and business agenda. Decision-makers, researchers and investors share the same space, for the first time in Brazil.

01

Phytotherapy, biodiversity and public health

Connecting Brazil's natural heritage, science and new therapeutic routes.

02

Public policy and national health systems

How public systems can catalyze regulated innovation at scale.

03

Innovation and technology for public health

AI, clinical data and infrastructure for a digital public health system.

04

Production and local arrangements

Industrial sovereignty, the healthcare economic complex and regional RTOs.

05

Access, financing and innovation funding

BNDES, Finep, FAPs, venture capital and shared-risk models.

06

Regulation and tech incorporation

ANVISA, Conitec, LGPD, intellectual property and regulatory AI.

Featured tags · Explainable AILGPDRegulatory validationBioequivalenceHealth sovereigntyCEISNIBPDPData spacesRegulatory sandboxRWDPharma 4.0
03 — Program

Two days to connect, validate and move the agenda.

A high-level program on federated infrastructure, AI for the pharmaceutical industry and new models of collaboration across science, business and regulation.

Final program · updated October 19, 2026
  1. 08:00 — 09:15
    Registration

    Registration and networking kick-off

  2. 09:15 — 09:30
    Opening

    Institutional opening

    • Daniel Callaghan Government Relations Manager · British Embassy Brasília
    • Daniela Longobucco Adviser to the Technology Directorate · FAPERJ
    • Ernesto Lembcke Technical Adviser · Health and Digital Policy · GIZ (DE)
    • Ricardo Leal Under-Secretary for Innovation and Productive Environments · Rio de Janeiro State Government
    • Ronaldo Pedro Founder · ConvergeLab
  3. 09:30 — 10:10
    Talk
    Act 1 — Ecosystems & Consortia

    Federated Data Ecosystems for Industry: European Lessons for Brazilian Value Chains

    • Kai Lindow Director of the Digital Engineering Division · Fraunhofer IPK
  4. 10:10 — 10:30
    Break

    Coffee break

  5. 10:30 — 11:00
    Talk
    Act 1 — Ecosystems & Consortia

    From Technology to Adoption: International Lessons on Federated Data Ecosystems

    • Calum Inverarity Senior Researcher · Open Data Institute
  6. 11:00 — 11:40
    Panel
    Act 1 — Ecosystems & Consortia

    Data Consortia and Industrial Innovation: Governance, Trust and Collaboration Models between the UK, Europe and Brazil

    About this act

    What has already been done and learnt internationally.

    • Kai Lindow Director of the Digital Engineering Division · Fraunhofer IPK
    • Calum Inverarity Senior Researcher · Open Data Institute
    • Moderator: Rodrigo Pastl
  7. 11:40 — 11:50
    Pitch
    Act 2 — Entrepreneurship

    From the Laboratory Bench to the Kitchen Counter: Science, Courage and Professional Reinvention

    • Elisângela Oliveira Hospitality and Participant Experience Coordination
  8. 11:50 — 13:20
    Lunch

    Networking lunch (lunch box)

  9. 13:20 — 13:40
    Talk
    Act 3 — Industrial Challenges & Convergence

    OpenSAFELY: From Secure Health Data Governance to Real-World Evidence (Lessons from the UK for Brazil)

    About this act

    How to turn industry pain points into structured opportunities for collaboration.

    • Martina Pesce Epidemiologist & Data Scientist · OpenSAFELY – Bennett Institute for Applied Data Science
  10. 13:40 — 14:20
    Talk
    Act 4 — Deep Tech Solutions & Use Cases

    In silico software, AI and the challenges of SUS (Brazil’s Unified Health System): multi-source data generation, AI-assisted cocrystals and federated computing in the development of new medicines

    • Alvaro Goyanes CEO · FabRx
    • Rodolpho Braga CTO · InsilicALL
    • Ronaldo Pedro Founder · NanoBusiness
  11. 14:20 — 14:40
    Break

    Coffee break

  12. 14:40 — 15:10
    Talk
    Act 4 — Deep Tech Solutions & Use Cases

    Use of AI in Drug Discovery from Brazilian Biodiversity: From Data Curation to the Discovery of New Medicines

    • Cristiano Guimarães CSO & Founder · Nintx
    • Denise Ferreira Sales & Government Relations · Latin America · CAS
    • Bruno Horta Executive Director · Peers
  13. 15:10 — 15:40
    Panel
    Act 4 — Deep Tech Solutions & Use Cases

    Use of AI in Drug Discovery from Brazilian Biodiversity: From Data Curation to the Discovery of New Medicines

    About this act

    Showing concretely what start-ups and technology partners can deliver.

    • Cristiano Guimarães CSO & Founder · Nintx
    • Denise Ferreira Sales & Government Relations · Latin America · CAS
    • Moderator: Bruno Horta
  14. 15:40 — 16:10
    Talk
    Act 5 — Data & Scientific Infrastructure

    The Challenge of Secure AI Training to Accelerate Drug Discovery Using Sensitive Brazilian Biodiversity Data Generated and Held in the Custody of LNBio/CNPEM

    • Hugo Verli Scientific Adviser to the Director · LNBio/CNPEM
  15. 16:10 — 16:40
    Talk
    Act 5 — Data & Scientific Infrastructure

    Market Intelligence Platform for Medicinal Plants, Phytomedicines and Herbal Products

    • Thais Catão Pharmacist, Medical Affairs Section · Bio-Manguinhos/Fiocruz
  16. 16:40 — 17:10
    Panel
    Act 5 — Data & Scientific Infrastructure

    From Biodiversity to Clinical Data: Building Trusted Environments for Sensitive Data, Artificial Intelligence and Health Research

    About this act

    How to let algorithms learn from sensitive scientific and industrial data without requiring it to be centralised.

    • Hugo Verli Scientific Adviser to the Director · LNBio/CNPEM
    • Thais Catão Pharmacist, Medical Affairs Section · Bio-Manguinhos/Fiocruz
    • Moderator: Filipe Gomes
  17. 17:10 — 18:10
    Networking

    B2B meetings and networking among participants, speakers and partners

Local time · Rio de Janeiro · BRT Times subject to minor changes
04 — Speakers

The decision-makers building the next generation of regulated healthcare.

Leaders connecting digital health, scientific infrastructure, artificial intelligence and pharmaceutical innovation.

Suggest a speaker
Ernesto Lembcke
01 Digital Health
GIZ · German–Brazilian Digital Dialogue

Ernesto Lembcke

Technical Advisor · Digital health and policy

A public-health and digital-transformation specialist with international experience in citizen-centred public systems.

Read full bio

An MSc graduate in Public Health from the London School of Hygiene and Tropical Medicine, he works across public health, migration and digital transformation. After roles in Mozambique, Peru, Kenya and Germany, he is now a Technical Advisor to GIZ’s German–Brazilian Digital Dialogue in Brasília, covering digital health, digital public infrastructure, emerging technologies and information integrity.

LinkedIn
Kai Lindow
02 Digital Engineering
Fraunhofer IPK

Kai Lindow

Director, Digital Engineering Division

He leads the strategy for digital technologies that create industrial value at Fraunhofer IPK.

Read full bio

Dr. Kai Lindow is an expert in digital technologies with a focus on data and model integration, digital ecosystems, data spaces and AI-driven solutions – always with an eye on business potential. For over a decade, he has been developing systemic approaches to make products and processes more efficient and resource-saving. After studying mechanical engineering in Berlin and Stockholm, he completed his PhD on “Knowledge-based development of sustainable products” at TU Berlin. Following his post-doctoral research at the interface of engineering and computer science, he became head of the Information and Process Control department at Fraunhofer IPK in Berlin, where he now serves as Director of Digital Engineering. He is actively involved in industrial and scientific working groups and a frequent voice on industry and research panels.

LinkedIn
Mateus Cardoso
03 Synchrotron Light
Sirius · LNLS / CNPEM

Mateus Cardoso

Head of the Soft and Biological Matter Division

He develops advanced synchrotron-light techniques to investigate high-resolution phenomena at the nano–bio interface.

Read full bio

At Sirius, he leads the development and application of synchrotron-light techniques for nanomedicine, nanotoxicology, health and environmental research. His strategic work spans the Sibipiruna, Timbó and Hibisco beamlines, integrated into Project Orion and high-containment environments for the safe study of complex biological systems.

LinkedIn
Rodolpho Braga
04 AI & Drug Discovery
InsilicAll / NanoBusiness

Rodolpho Braga

Founder & Chief Technology Officer

A Medicinal Chemistry PhD with more than a decade of work in AI, predictive modelling and regulatory toxicology.

Read full bio

He has over ten years of experience in predictive modelling, analytics and data science for pharmaceutical innovation and regulatory toxicology. He is founder and CTO of NanoBusiness and InsilicAll, a Latin American platform combining artificial intelligence and computational methods to accelerate small molecules, protein therapeutics and toxicological safety assessments.

LinkedIn
Fabricio Vargas
05 Pharma 4.0
InsilicAll

Fabricio Vargas

Chief Executive Officer

An R&D executive with 18 years of experience across the pharmaceutical and chemical industries.

Read full bio

A chemistry professional with 18 years of experience in Research, Development and Innovation. He has led multidisciplinary technical teams, new-product development and global strategic projects. As CEO of InsilicAll, he drives the company’s growth and international expansion by connecting deep chemistry expertise with artificial intelligence.

LinkedIn
Ronaldo Pedro
06 Deep Tech
NanoBusiness · ConvergeLab

Ronaldo Pedro

Founder & Principal Investigator

For more than 20 years he has turned nanotechnology, biotechnology and AI into pharmaceutical solutions and deep-tech ventures.

Read full bio

He has over 20 years of experience in research, development and innovation focused on advanced materials and pharmaceutical solutions. He is founder and Principal Investigator at NanoBusiness and ConvergeLab Venture Builder, de-risking deep-tech opportunities for investors, researcher-entrepreneurs and startups. He also teaches Innovation and Entrepreneurship at UFRJ.

LinkedIn
Cristiano R. W. Guimarães
07 Medicinal Chemistry
Nintx

Cristiano R. W. Guimarães

Co-founder & Chief Scientific Officer

A theoretical chemist with a track record at Amgen, Pfizer and Aché, now leading Nintx.

Read full bio

He received his PhD in Theoretical and Organic Chemistry from the Federal University of Rio de Janeiro in 2001, followed by a postdoctorate with Prof. William Jorgensen at Yale University. He worked at Amgen and then Pfizer, both in the US, as a Senior Principal Scientist. In 2014 he returned to Brazil to lead the Radical Innovation Unit at Aché Laboratórios Farmacêuticos, focused on the discovery and early development of new chemical entities from synthetic and natural sources, and was promoted to Senior Director, Research, Innovation & New Technologies in 2020. He left Aché to start, with Dr. Miller Freitas and Mr. Stephani Saverio, a Brazilian company called Nintx (Next Innovative Therapeutics), which draws on intra- and interspecies biology and derived natural products to generate novel human therapies. He is the author of some 70 publications and patents.

LinkedIn
Denise Ferreira
08 Scientific Information
CAS · American Chemical Society

Denise Ferreira

Sales & Government Relations · Latin America

A scientist trained at USP and Uppsala, she leads ACS sales and government relations across Latin America.

Read full bio

She started as a scientist at USP, then completed a PhD and postdoc at Uppsala University in Sweden. She quickly realised her strength lay not only in generating knowledge but in connecting it: ideas with action, science with decision-making, people with purpose. That belief led her from academia into industry, first pharma and then scientific information and data. For over a decade she has been with the American Chemical Society, where she currently leads Sales and Government Relations for Latin America, doubling and tripling key contracts, negotiating multimillion-dollar agreements and deepening institutional partnerships across Brazil and the region. She advocates for gender equity in STEM and scientific capacity building in the Global South.

Bruno Horta
09 Data & AI
Peers

Bruno Horta

Executive Director · Head of Analytics & AI

A UFRJ PhD with a postdoc at ETH-Zürich, applying data science to R&D and operations.

Read full bio

Head of Data Analytics & Artificial Intelligence at Peers, he holds a PhD in Sciences from UFRJ and a postdoctoral degree in Computer Simulation from ETH-Zürich, Switzerland. He has been involved in computational research for over 15 years and has published more than 70 international scientific articles, and has been invited to speak in several countries. An entrepreneur, he founded and served as CEO of a data science startup. He has worked on projects with renowned companies in Brazil and abroad, mainly applying data science to R&D, supply chain, customer success and business expansion.

LinkedIn
Gerrit Glass
10 Healthtech
Open Health Technologies

Gerrit Glass

Chief Executive Officer

An entrepreneur with a track record leading fintech and healthtech companies across Europe and the Americas.

Read full bio

An experienced entrepreneur and startup executive with a strong international network and a solid track record leading fintech and healthtech companies across Europe and the Americas. He is currently the CEO of Open Health Technologies. He studied Business Informatics and IT Management in Berlin and London. Beyond his professional activities, he has a strong interest in biohacking, self-improvement and sports.

LinkedIn
Victor Arnaud
11 Digital Infrastructure
Equinix

Victor Arnaud

President, Brazil

President of Equinix in Brazil and a leading figure in Latin American digital infrastructure.

Read full bio

President of Equinix in Brazil and one of the leading figures in Latin America’s digital infrastructure sector. With more than 20 years at the company, he has built a career marked by strategic vision, deep technical knowledge and a central role in the country’s digital transformation. In his current position he leads Equinix’s expansion in Brazil, with billions of reais invested in recent years, consolidating the country as a regional hub for interconnection, cloud and AI. He also sits on the board of the Equinix Foundation and the Advisory Board of Escola da Nuvem, reaffirming his commitment to social responsibility and technology’s positive impact on society.

LinkedIn
Claudio Frazão
12 AI Infrastructure
Equinix

Claudio Frazão

Senior Manager · AI Infrastructure Managed Services

He leads technical development of Equinix’s IaaS and Private AI platforms.

Read full bio

Senior Manager, AI Infrastructure Managed Services Solution Development at Equinix, where for more than 14 years he has built and operated the services underpinning the company’s global Managed Services operation. He currently leads the technical development of the platforms behind Equinix’s IaaS and Private AI portfolio, including NVIDIA DGX SuperPOD and Dell AI Factory solutions, running across AMER, EMEA and APAC. He is NVIDIA Certified in AI Infrastructure and Operations, an alumnus of Wharton’s Leading an AI-Powered Future programme and holds an Executive MBA in Entrepreneurship and New Business Development from FGV. He writes and speaks about the economics of AI infrastructure in production.

Thaís Catão
13 HTA & Public Health
Bio-Manguinhos · Fiocruz

Thaís Catão

Pharmacist · Medical Affairs Section

A pharmacist working across public health policy, pharmacoeconomics and health technology assessment.

Read full bio

She works in innovation at Bio-Manguinhos/Fiocruz, in the Medical Affairs department. Her research covers public health policy, pharmacoeconomics and health technology assessment (HTA), aimed at optimising the use of resources and ensuring the sustainability of Brazil’s public health system. She coordinates the Technical Group of Pharmacists for Racial Equality at CRF/RJ. She has experience as a hospital pharmacist at Hospital Pró-Cardíaco and in primary care within the public health system. Between 2019 and 2024 she was a partner and manager of the independent cultural centre MOTIM, responsible for financial management and strategic planning.

Renato Cerqueira
14 Governable AI
PUC-Behring AI Institute · PUC-Rio

Renato Cerqueira

Director

Former IBM Research leader, now heading the PUC-Behring Institute for Artificial Intelligence.

Read full bio

Director of the PUC-Behring Institute for Artificial Intelligence at the Pontifical Catholic University of Rio de Janeiro, with a career spanning artificial intelligence, decision-making and knowledge management. From 2011 to 2025 he was a Senior Research Manager at IBM Research, where he helped create the company’s research lab in Brazil and led AI initiatives in oil and gas, sustainable materials, mining, agriculture and finance. In 2026 he returned to PUC-Rio’s Department of Informatics as a professor. He holds a degree in Computer Engineering from PUC-Rio, a master’s and PhD in Informatics from the same university, and a postdoctorate from the University of Illinois Urbana-Champaign. At the Summit he presents the talk “Governable AI for Applied Discovery”.

LinkedIn
Hugo Verli
15 Bioinformatics
LNBio · CNPEM

Hugo Verli

Scientific Advisor to the Director

Bioinformatics and molecular modelling applied to finding new targets and drug candidates.

Read full bio

Scientific Advisor at the Brazilian Biosciences National Laboratory (LNBio/CNPEM) and a researcher in bioinformatics, molecular modelling and computational biology. He is an Associate Professor at the Biotechnology Center of UFRGS, with a degree in Pharmacy, a master’s in Pharmaceutical Sciences and a PhD in Cellular and Molecular Biology. His research focuses on the structure and dynamics of biomolecules, with special emphasis on glycans and glycoproteins, on building software and tools for bioinformatics, and on the search for new therapeutic targets and drug candidates.

LinkedIn
Martina Pesce
16 Epidemiology
OpenSAFELY

Martina Pesce

Epidemiologist

A physician-epidemiologist using routinely collected data to fight infectious disease.

Read full bio

An epidemiologist with a background in medicine and public health, she currently works on OpenSAFELY. She previously worked as an epidemiologist at Argentina’s Ministry of Health, contributing to national COVID-19 surveillance and vaccine monitoring strategies. Her interest lies in using routinely collected data to tackle infectious diseases and reduce health inequalities. She graduated in Medicine from the University of Buenos Aires, specialised in Epidemiology through the Argentine Ministry of Health’s training programme, and holds an MSc in Public Health for Development from the London School of Hygiene and Tropical Medicine.

LinkedIn
Francisco Salvatelli
17 Biotech Venture
GRIDX

Francisco Salvatelli

Partner & Director

Turning scientific discoveries into biotech companies across Latin America.

Read full bio

Partner and Director at GRIDX, a venture capital firm and accelerator for biotech startups in Latin America. With more than 15 years at the intersection of innovation, agribusiness and sustainability, he has broad experience in the agricultural markets of Brazil and Argentina. An agronomist by training, he focuses on developing and scaling high-impact scientific solutions. At GRIDX he leads the process of turning scientific discoveries into biotech-based deep tech companies, connecting scientists, entrepreneurs and investors to drive the next generation of food, health and environmental sustainability in the region.

LinkedIn
Guilherme Santos
18 Innovation Ecosystems
ECOA Institute · PUC-Rio · FAPERJ

Guilherme Santos

Innovation Consultant · Advisor to FAPERJ’s Technology Board

A specialist in innovation ecosystems and mission-oriented policy.

Read full bio

A specialist in innovation, entrepreneurship ecosystems and mission-oriented policy. He holds a bachelor’s degree and teaching licence in Social Sciences, and a master’s and PhD in Public Policy, Strategy and Development from the Federal University of Rio de Janeiro (UFRJ). With a track record linking science, technology and socio-economic impact, he advises FAPERJ’s Technology Board and is an Innovation Consultant at the ECOA Institute/PUC-Rio, bringing academia, the public sector and the market together.

LinkedIn
Cristiane Rodella
19 Synchrotron Light
LNLS · CNPEM

Cristiane Rodella

Head of the Paineira Group

Leads LNLS’s X-ray diffraction group, covering Sirius’s PAINEIRA and JATOBÁ beamlines.

Read full bio

She holds a degree in Physics, a master’s in Applied Physics and a PhD in Materials Science and Engineering, all from the University of São Paulo, and completed two postdoctoral stays in Inorganic Chemistry at UNICAMP. She has worked at the Brazilian Synchrotron Light Laboratory (LNLS-CNPEM) since 2005. Today she is an LNLS researcher and coordinates PAINEIRA, the polycrystalline X-ray diffraction beamline at Sirius, Brazil’s fourth-generation synchrotron light source. She leads the LNLS XPD Group, which brings together the PAINEIRA and JATOBÁ teams, the latter being the pair distribution function (PDF) beamline. Her research covers heterogeneous catalysis and materials and devices for energy storage, with an emphasis on structure–function characterisation through in situ and operando experiments using synchrotron techniques.

LinkedIn
Elisângela Oliveira
20 Science & Food
ConvergeLab Summit

Elisângela Oliveira

Hospitality & Participant Experience Coordination

A biologist and chef bringing together science, food and social change.

Read full bio

A biologist from the Federal University of Rio de Janeiro (UFRJ), with a master’s in Science and Health Education and a PhD in Sciences with an emphasis on Microbiology. Her scientific career includes time at the Albert Einstein College of Medicine in New York and the Jenner Institute at the University of Oxford. Along the way, her work took on a new dimension by bringing science, food and social change closer together. She is a Living Food educator certified by Fiocruz, a chef trained at Le Cordon Bleu, holds training in Social Gastronomy from Gastromotiva, and works in functional gastronomy, food safety and healthy eating.

Daniel Callaghan
21 UK–Brazil Cooperation
British Embassy Brasília · FCDO

Daniel Callaghan

Government Relations Manager

Connects government, industry and innovation policy in life sciences between the UK and Brazil.

Read full bio

Specialist in institutional relations, public policy and government affairs, with solid experience in the life sciences sector. His work sits at the interface between government, industry and innovation policy, contributing to institutional dialogue and international cooperation in strategic areas for health. Working within the context of British cooperation in Brazil, he takes part in initiatives that strengthen the connections between the UK and Brazilian innovation ecosystems.

LinkedIn
Daniela Longobucco
22 Innovation Funding
FAPERJ · UFRJ Caxias Campus

Daniela Longobucco

Adviser to the Technology Directorate

Runs the TECNOVA and Centelha calls at FAPERJ and mentors start-ups in Rio de Janeiro.

Read full bio

PhD and MSc in Business Administration. She is an adviser to FAPERJ’s Technology Directorate, where she manages the TECNOVA and Centelha funding calls, and a lecturer at UFRJ’s Caxias Campus in Product Engineering, Production Management and Business Administration. She also advises start-ups in programmes and incubators in Rio de Janeiro.

LinkedIn
Rodrigo Pastl
23 Industry 4.0
Ceará Tech Park · SENAI/CE

Rodrigo Pastl

Head of Operations

Former head of Fraunhofer’s Brazil office, connecting applied research, technology and industry.

Read full bio

PhD in Engineering from the Technical University of Berlin and MSc from ITA, with more than 15 years of international experience in industrial innovation, Industry 4.0 and digital transformation. He was Director of the Fraunhofer Office in Brazil (2020–2024) and has worked at CNI, Vale and international organisations. He leads operations at Ceará Tech Park (SENAI/CE), is a postdoctoral researcher at ITA and founded Lean 4.0, connecting applied research, technology and industry.

LinkedIn
Filipe Gomes
24 Deep Tech Commercialisation
Digital Catapult

Filipe Gomes

Principal Innovation Solutions Consultant

Nearly 20 years in deep tech strategy and commercialisation across the UK, Brazil and the Middle East.

Read full bio

PhD from Birkbeck, University of London, with research on innovation intermediaries in emerging economies. He has nearly 20 years of international experience in strategy, innovation and the commercialisation of deep tech in the UK, Brazil and the Middle East. He is a Principal Innovation Solutions Consultant at Digital Catapult, where he develops programmes, strategic partnerships and initiatives to accelerate and grow technology businesses.

LinkedIn
Fanny Costa
25 Crystallography
Bragg Centre · University of Leeds

Fanny Costa

Director of the X-ray Analytical Unit

Specialist in X-ray powder diffraction and pharmaceutical polymorphism.

Read full bio

Specialist in crystallography and X-ray powder diffraction (XRPD), with experience in pharmaceutical polymorphism, quantitative phase analysis and amorphous materials. She has worked at Diamond Light Source and Excelsus Structural Solutions, applying advanced synchrotron, total scattering and PDF techniques. She is Director of the X-ray Analytical Unit at the Bragg Centre for Materials Research, University of Leeds, UK.

LinkedIn
Jefferson de Oliveira Gomes
26 Industrial Policy
CNI · ITA

Jefferson de Oliveira Gomes

Director of Industrial Development, Technology and Innovation

ITA professor and former CEO of IPT, bringing together science, technology and industry.

Read full bio

PhD in Mechanical Engineering from UFSC, professor at ITA since 2004 and Director of Industrial Development, Technology and Innovation at CNI (National Confederation of Industry). He led the Fraunhofer Project Center at ITA, helped build the SENAI Innovation Institutes network and was CEO of IPT (2019–2021). He has more than 20 years of experience in applied research, innovation management and industrial policy, bringing together science, technology and industry.

LinkedIn
Charles Prado
27 Trustworthy AI
Inmetro

Charles Prado

Coordinator of the Artificial Intelligence Centre (CIAI)

Governance, evaluation and standardisation of trustworthy artificial intelligence systems.

Read full bio

Researcher and technology specialist working at the intersection of Artificial Intelligence, Digital Metrology, Trustworthy AI and Critical Infrastructure. He is Coordinator of the Inmetro Artificial Intelligence Centre (CIAI), with activities focused on AI governance, digital transformation, AI evaluation methods, standardisation initiatives and trustworthy AI ecosystems.

LinkedIn
Calum Inverarity
28 Data & Governance
Open Data Institute (ODI)

Calum Inverarity

Senior Researcher

Researches the interplay between science, technology and society and what it asks of contemporary governance.

Read full bio

Calum Inverarity is a Senior Researcher with the Research & Development team at the Open Data Institute (ODI). His interests lie in the interplay between science, technology and society, and the questions this asks of contemporary governance. He has previously worked with think tanks and research institutes in the UK and Belgium focusing on international security, economic policy and conflict resolution. Some of his previous research has explored decision making within complex systems, the science-policy nexus, illiberal democracy and post-conflict constitutional reform. He received his MSc from the University of Amsterdam and completed his BA at the University of Leeds, having spent periods studying at the University of California, San Diego and the University of Ghana.

LinkedIn
José María Veganzones
29 Health Data Spaces
Consejería de Digitalización · Comunidad de Madrid

José María Veganzones

Subdirector General de Innovación y Soluciones Asistenciales

Over 25 years leading AI, Big Data and data governance projects in public health.

Read full bio

Physician, electronic engineer and industrial technical engineer. He holds postgraduate degrees in AI for the Public Sector (AI4Gov) and Health Innovation Management, and researches AI and the EHDS (European Health Data Space) applied to clinical trials. He has more than 25 years of experience leading AI, Big Data and data governance projects. He was head of the Information Systems and Data Analysis Area at Spain’s Ministry of Health and Deputy Director General at the Community of Madrid, where he led health data spaces.

LinkedIn
Lucas Delgado
30 Deep Tech Innovation
Emerge

Lucas Delgado

Co-founder & Managing Partner

Turns R&D and innovation into competitive advantage and runs the Deep Tech Summit.

Read full bio

Co-founder and Managing Partner of Emerge, a leading Latin American consultancy for companies, investors and public institutions that need to turn R&D and innovation into competitive advantage. He works in strategic R&D consulting focused on frontier technologies and in qualified technology scouting, mapping start-ups, universities and research centres. He runs the Deep Tech Summit, the largest deep tech event in Latin America, with more than 2,500 participants among investors, start-ups and executives. A production engineer specialised in financial management, he is also a deep tech investor and CFO of Peptidus, a biotech developing an AI-driven drug discovery platform for therapeutic peptides in animal health.

LinkedIn
Ricardo Leal
31 Innovation Ecosystems
Rio de Janeiro State Government · UFF

Ricardo Leal

Under-Secretary for Innovation and Productive Environments

Engineer with a PhD from MIT, connecting university, industry and government for innovation in Rio.

Read full bio

Metallurgical engineer from IME, with an MSc in Materials Science and a PhD from MIT (USA). He is Under-Secretary for Innovation and Productive Environments of the State of Rio de Janeiro and has been an Associate Professor at UFF since 1986. He led UFF’s Innovation Agency (AGIR) for nine years, expanding its innovation environments. He has 30 years of experience in the steel industry at CSN, ArcelorMittal and Votorantim, and was also a Director and Board Member of ABM.

LinkedIn
Alvaro Goyanes
32 3D-Printed Pharmaceuticals
FabRx · London

Alvaro Goyanes

Co-Founder & CEO

Pioneer in 3D-printed medicines and personalised medicine.

Read full bio

Co-Founder and CEO of FabRx (London, UK), a pioneering company in 3D-printed pharmaceuticals and medical devices. With over 15 years of experience in pharmaceutics, he is a leading researcher in personalised medicine and pharmaceutical 3D printing. Recognised as a Highly Cited Researcher by Web of Science since 2019, he is also an Honorary Lecturer at University College London (UCL) and a part-time lecturer at the University of Santiago de Compostela, Spain.

LinkedIn

Confirmed speakers · updated October 19, 2026

05 — Registration

Your brand at the center of the next revolution.

Receive the complete Summit material (program, sponsorship profiles and matchmaking opportunities) directly in your inbox.

Partnerships
contact@convergelab.org
Lettycia Terto · Ronaldo Pedro
Venue
Av. das Américas, 2480
Rio de Janeiro · RJ · BR
Form · 01 of 01
Get the complete material
What's your main interest?
Your data is safe with us · No spam